Cite Filings / CMPX / 0001140361-26-017649

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Compass Therapeutics, Inc. Filed 2026-04-29 Acc 0001140361-26-017649

Documents 1

DEF 14A Proxy Statement , edge20068103x1_def14a.htm

Around this filing

2026-04-30 4/A Chief Accounting Officer bought 15,000 shares at $1.89 ($28,350)
2026-04-29 4 General Counsel acquired 25,000 shares (grant or award)
2026-04-29 4 Chief Accounting Officer acquired 15,000 shares (grant or award)
2026-04-29 ARS Annual Report to Security Holders
2026-04-29 DEFA14A Proxy Materials
2026-04-29 DEF 14A Proxy Statement
2025-04-29 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading edge20068103x1_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…